Evidence map›Paper›PMID 37701383›Full record

ReviewLe infezioni in medicina2023

Evolution of

Yelson Alejandro Picón-Jaimes, Ivan David Lozada-Martinez, María Camila Forero Buelvas, Andrés Felipe Ardila Sarmiento, Gustavo Adolfo Serrano Baez, Deilly Yohana Nazareno Erazo, José Daniel Cuastumal Martínez, Franklin Kevin Ruiz-Gutierrez, Victor Daniel Carreño Barrera

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Le infezioni in medicina, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Yelson Alejandro Picón-JaimesFac Ciències Salut Blanquerna, Univ Ramon Llul, Barcelona, Spain.
Ivan David Lozada-MartinezEpidemiology Program, Department of Graduate Studies in Health Sciences, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.
María Camila Forero BuelvasSchool of Medicine, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.
Andrés Felipe Ardila SarmientoSchool of Medicine, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.
Gustavo Adolfo Serrano BaezDepartment of Intensive Care, Clínica de Urgencias Bucaramanga, Bucaramanga, Colombia.
Deilly Yohana Nazareno ErazoDepartament of Medicine, Universidad del Cauca, Popayán, Colombia.
José Daniel Cuastumal MartínezDepartament of Medicine, Universidad del Cauca, Popayán, Colombia.
Franklin Kevin Ruiz-GutierrezDepartment of Intensive Care, Hospital Felix Bulnes Cerda, Santiago de Chile, Chile.
Victor Daniel Carreño BarreraDepartment of Medicine, Universidad de Santander, Bucaramanga, Colombia.
Universidad Autónoma de Bucaramanga · COUniversitat Ramon Llull · ESUniversity of Santander · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Duffy protein, a transmembrane molecule, acts as a receptor for various chemokines and facilitates binding between reticulocytes and the

Indexed as

disease resistanceduffy blood-group systemmalariaPlasmodiumPlasmodium vivax

Identifiers

PMID37701383
PMCPMC10495050
OpenAlexW4386704440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.